Diabetes Metab J.  2022 Sep;46(5):781-802. 10.4093/dmj.2021.0189.

Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis

Affiliations
  • 1Centre for Research on Ageing, Health and Wellbeing, The Australian National University, Canberra, Australia

Abstract

Background
Type 2 diabetes mellitus (T2DM) is known to be associated with cognitive decline and brain structural changes. This study systematically reviews and estimates human brain volumetric differences and atrophy associated with T2DM.
Methods
PubMed, PsycInfo and Cochrane Library were searched for brain imaging studies reporting on brain volume differences between individuals with T2DM and healthy controls. Data were examined using meta-analysis, and association between age, sex, diabetes characteristics and brain volumes were tested using meta-regression.
Results
A total of 14,605 entries were identified; after title, abstract and full-text screening applying inclusion and exclusion criteria, 64 studies were included and 42 studies with compatible data contributed to the meta-analysis (n=31,630; mean age 71.0 years; 44.4% male; 26,942 control; 4,688 diabetes). Individuals with T2DM had significantly smaller total brain volume, total grey matter volume, total white matter volume and hippocampal volume (approximately 1% to 4%); meta-analyses of smaller samples focusing on other brain regions and brain atrophy rate in longitudinal investigations also indicated smaller brain volumes and greater brain atrophy associated with T2DM. Meta-regression suggests that diabetes-related brain volume differences start occurring in early adulthood, decreases with age and increases with diabetes duration.
Conclusion
T2DM is associated with smaller total and regional brain volume and greater atrophy over time. These effects are substantial and highlight an urgent need to develop interventions to reduce the risk of T2DM for brain health.

Keyword

Atrophy; Brain; Diabetes mellitus; type 2; Neuroimaging

Figure

  • Fig. 1 Flowchart of the screening and inclusion of studies into the systematic review and meta-analysis.

  • Fig. 2 Forest plots of differences in global brain volumes and total brain atrophy rate between participants with and without type 2 diabetes mellitus. (A) Total brain volume difference, (B) grey matter volume difference, (C) white matter volume difference, (D) total brain atrophy difference. CI, confidence interval.

  • Fig. 3 Funnel plots of brain volumes and atrophy rate assessing possible publication bias using the trim and fill method. Filled circles represent studies included in the meta-analysis. Open circles represent possible missing studies. Brain volumes: (A) total brain volume, (B) grey matter, (C) white matter, (D) hippocampus, (E) thalamus, (F) caudate, (G) putamen, (H) globus pallidus, (I) amygdala, (J) nucleus accumbens, (K) superior temporal gyrus, (L) frontal lobe, (M) cerebrospinal fluid, (N) white matter hyperintensity, and (O) total brain atrophy rate._(Continued to the next page)


Cited by  2 articles

Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis (Diabetes Metab J 2022;46:781-802)
Se Hee Min
Diabetes Metab J. 2022;46(5):813-814.    doi: 10.4093/dmj.2022.0259.

Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis (Diabetes Metab J 2022;46:781-802)
Tianqi Zhang, Marnie Shaw, Nicolas Cherbuin
Diabetes Metab J. 2022;46(5):815-816.    doi: 10.4093/dmj.2022.0296.


Reference

1. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013; 93:137–88.
Article
2. Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012; 42:484–91.
Article
3. Cherbuin N, Walsh EI. Sugar in mind: untangling a sweet and sour relationship beyond type 2 diabetes. Front Neuroendocrinol. 2019; 54:100769.
Article
4. Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev. 2008; 29:494–511.
Article
5. Kawamura T, Umemura T, Hotta N. Cognitive impairment in diabetic patients: can diabetic control prevent cognitive decline? J Diabetes Investig. 2012; 3:413–23.
Article
6. van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ. Brain imaging in patients with diabetes: a systematic review. Diabetes Care. 2006; 29:2539–48.
7. Manschot SM, Brands AM, van der Grond J, Kessels RP, Algra A, Kappelle LJ, et al. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes. 2006; 55:1106–13.
Article
8. Tiehuis AM, van der Graaf Y, Visseren FL, Vincken KL, Biessels GJ, Appelman AP, et al. Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease. Stroke. 2008; 39:1600–3.
Article
9. Manschot SM, Biessels GJ, de Valk H, Algra A, Rutten GE, van der Grond J, et al. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia. 2007; 50:2388–97.
Article
10. Bruehl H, Sweat V, Tirsi A, Shah B, Convit A. Obese adolescents with type 2 diabetes mellitus have hippocampal and frontal lobe volume reductions. Neurosci Med. 2011; 2:34–42.
Article
11. Espeland MA, Bryan RN, Goveas JS, Robinson JG, Siddiqui MS, Liu S, et al. Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women’s Health Initiative Magnetic Resonance Imaging studies. Diabetes Care. 2013; 36:90–7.
12. de Bresser J, Tiehuis AM, van den Berg E, Reijmer YD, Jongen C, Kappelle LJ, et al. Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care. 2010; 33:1309–14.
Article
13. van Elderen SG, de Roos A, de Craen AJ, Westendorp RG, Blauw GJ, Jukema JW, et al. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology. 2010; 75:997–1002.
Article
14. Kooistra M, Geerlings MI, Mali WP, Vincken KL, van der Graaf Y, Biessels GJ, et al. Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease: the SMART-MR study. J Neurol Sci. 2013; 332:69–74.
Article
15. Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011; 77:461–8.
Article
16. Fraser MA, Shaw ME, Cherbuin N. A systematic review and meta-analysis of longitudinal hippocampal atrophy in healthy human ageing. Neuroimage. 2015; 112:364–74.
Article
17. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71.
18. R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing;2014.
19. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010; 36:1–48.
20. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-analysis. Chichester: Wiley;2011.
21. Samaras K, Lutgers HL, Kochan NA, Crawford JD, Campbell LV, Wen W, et al. The impact of glucose disorders on cognition and brain volumes in the elderly: the Sydney Memory and Ageing Study. Age (Dordr). 2014; 36:977–93.
Article
22. Ajilore O, Narr K, Rosenthal J, Pham D, Hamilton L, Watari K, et al. Regional cortical gray matter thickness differences associated with type 2 diabetes and major depression. Psychiatry Res. 2010; 184:63–70.
Article
23. Ajilore O, Lamar M, Medina J, Watari K, Elderkin-Thompson V, Kumar A. Disassociation of verbal learning and hippocampal volume in type 2 diabetes and major depression. Int J Geriatr Psychiatry. 2015; 30:393–9.
Article
24. Armstrong NM, An Y, Beason-Held L, Doshi J, Erus G, Ferrucci L, et al. Predictors of neurodegeneration differ between cognitively normal and subsequently impaired older adults. Neurobiol Aging. 2019; 75:178–86.
Article
25. van Bloemendaal L, Ijzerman RG, Ten Kulve JS, Barkhof F, Diamant M, Veltman DJ, et al. Alterations in white matter volume and integrity in obesity and type 2 diabetes. Metab Brain Dis. 2016; 31:621–9.
Article
26. Bruehl H, Wolf OT, Convit A. A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus. Psychoneuroendocrinology. 2009; 34:815–21.
Article
27. Bruehl H, Wolf OT, Sweat V, Tirsi A, Richardson S, Convit A. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res. 2009; 1280:186–94.
Article
28. Brundel M, van den Heuvel M, de Bresser J, Kappelle LJ, Biessels GJ; Utrecht Diabetic Encephalopathy Study Group. Cerebral cortical thickness in patients with type 2 diabetes. J Neurol Sci. 2010; 299:126–30.
Article
29. Brundel M, Reijmer YD, van Veluw SJ, Kuijf HJ, Luijten PR, Kappelle LJ, et al. Cerebral microvascular lesions on high-resolution 7-Tesla MRI in patients with type 2 diabetes. Diabetes. 2014; 63:3523–9.
Article
30. Callisaya ML, Beare R, Moran C, Phan T, Wang W, Srikanth VK. Type 2 diabetes mellitus, brain atrophy and cognitive decline in older people: a longitudinal study. Diabetologia. 2019; 62:448–58.
Article
31. Chen X, Wen W, Anstey KJ, Sachdev PS. Effects of cerebrovascular risk factors on gray matter volume in adults aged 60–64 years: a voxel-based morphometric study. Psychiatry Res. 2006; 147:105–14.
Article
32. Chen Z, Li L, Sun J, Ma L. Mapping the brain in type II diabetes: voxel-based morphometry using DARTEL. Eur J Radiol. 2012; 81:1870–6.
Article
33. Chen Z, Li J, Sun J, Ma L. Brain expansion in patients with type II diabetes following insulin therapy: a preliminary study with longitudinal voxel-based morphometry. J Neuroimaging. 2014; 24:484–91.
Article
34. Chen J, Zhang J, Liu X, Wang X, Xu X, Li H, et al. Abnormal subcortical nuclei shapes in patients with type 2 diabetes mellitus. Eur Radiol. 2017; 27:4247–56.
Article
35. Climie RE, Srikanth V, Beare R, Keith LJ, Fell J, Davies JE, et al. Aortic reservoir characteristics and brain structure in people with type 2 diabetes mellitus; a cross sectional study. Cardiovasc Diabetol. 2014; 13:143.
Article
36. Cox SR, Lyall DM, Ritchie SJ, Bastin ME, Harris MA, Buchanan CR, et al. Associations between vascular risk factors and brain MRI indices in UK Biobank. Eur Heart J. 2019; 40:2290–300.
Article
37. Cui X, Abduljalil A, Manor BD, Peng CK, Novak V. Multi-scale glycemic variability: a link to gray matter atrophy and cognitive decline in type 2 diabetes. PLoS One. 2014; 9:e86284.
Article
38. Cui Y, Liang X, Gu H, Hu Y, Zhao Z, Yang XY, et al. Cerebral perfusion alterations in type 2 diabetes and its relation to insulin resistance and cognitive dysfunction. Brain Imaging Behav. 2017; 11:1248–57.
Article
39. Cui Y, Tang TY, Lu CQ, Cai Y, Lu T, Wang YC, et al. Abnormal cingulum bundle induced by type 2 diabetes mellitus: a diffusion tensor tractography study. Front Aging Neurosci. 2020; 12:594198.
Article
40. de Bresser J, Kuijf HJ, Zaanen K, Viergever MA, Hendrikse J, Biessels GJ, et al. White matter hyperintensity shape and location feature analysis on brain MRI; proof of principle study in patients with diabetes. Sci Rep. 2018; 8:1893.
Article
41. den Heijer T, Vermeer SE, van Dijk EJ, Prins ND, Koudstaal PJ, Hofman A, et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia. 2003; 46:1604–10.
Article
42. Fang F, Zhan YF, Zhuo YY, Yin DZ, Li KA, Wang YF. Brain atrophy in middle-aged subjects with type 2 diabetes mellitus, with and without microvascular complications. J Diabetes. 2018; 10:625–32.
Article
43. Fang F, Lai MY, Huang JJ, Kang M, Ma MM, Li KA, et al. Compensatory hippocampal connectivity in young adults with early-stage type 2 diabetes. J Clin Endocrinol Metab. 2019; 104:3025–38.
Article
44. Ferreira FS, Pereira JM, Reis A, Sanches M, Duarte JV, Gomes L, et al. Early visual cortical structural changes in diabetic patients without diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2017; 255:2113–8.
Article
45. Ferreira FS, Pereira JM, Duarte JV, Castelo-Branco M. Extending inferential group analysis in type 2 diabetic patients with multivariate GLM implemented in SPM8. Open Neuroimag J. 2017; 11:32–45.
Article
46. Gold SM, Dziobek I, Sweat V, Tirsi A, Rogers K, Bruehl H, et al. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia. 2007; 50:711–9.
Article
47. Hempel R, Onopa R, Convit A. Type 2 diabetes affects hippocampus volume differentially in men and women. Diabetes Metab Res Rev. 2012; 28:76–83.
Article
48. Hirabayashi N, Hata J, Ohara T, Mukai N, Nagata M, Shibata M, et al. Association between diabetes and hippocampal atrophy in elderly Japanese: the Hisayama Study. Diabetes Care. 2016; 39:1543–9.
Article
49. Hoogendam YY, van der Geest JN, van der Lijn F, van der Lugt A, Niessen WJ, Krestin GP, et al. Determinants of cerebellar and cerebral volume in the general elderly population. Neurobiol Aging. 2012; 33:2774–81.
Article
50. Hsu JL, Chen YL, Leu JG, Jaw FS, Lee CH, Tsai YF, et al. Microstructural white matter abnormalities in type 2 diabetes mellitus: a diffusion tensor imaging study. Neuroimage. 2012; 59:1098–105.
Article
51. Jongen C, van der Grond J, Kappelle LJ, Biessels GJ, Viergever MA, Pluim JP, et al. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia. 2007; 50:1509–16.
Article
52. Kumar R, Anstey KJ, Cherbuin N, Wen W, Sachdev PS. Association of type 2 diabetes with depression, brain atrophy, and reduced fine motor speed in a 60- to 64-year-old community sample. Am J Geriatr Psychiatry. 2008; 16:989–98.
Article
53. Kumar A, Haroon E, Darwin C, Pham D, Ajilore O, Rodriguez G, et al. Gray matter prefrontal changes in type 2 diabetes detected using MRI. J Magn Reason Imaging. 2008; 27:14–9.
Article
54. Last D, Alsop DC, Abduljalil AM, Marquis RP, de Bazelaire C, Hu K, et al. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care. 2007; 30:1193–9.
Article
55. Launer LJ, Lewis CE, Schreiner PJ, Sidney S, Battapady H, Jacobs DR, et al. Vascular factors and multiple measures of early brain health: CARDIA brain MRI study. PLoS One. 2015; 10:e0122138.
Article
56. Lee JH, Yoon S, Renshaw PF, Kim TS, Jung JJ, Choi Y, et al. Morphometric changes in lateral ventricles of patients with recent-onset type 2 diabetes mellitus. PLoS One. 2013; 8:e60515.
Article
57. Li W, Risacher SL, Huang E, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative. Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort. Neurology. 2016; 87:595–600.
Article
58. Li C, Li C, Yang Q, Wang B, Yin X, Zuo Z, et al. Cortical thickness contributes to cognitive heterogeneity in patients with type 2 diabetes mellitus. Medicine (Baltimore). 2018; 97:e10858.
Article
59. Liu J, Rutten-Jacobs L, Liu M, Markus HS, Traylor M. Causal impact of type 2 diabetes mellitus on cerebral small vessel disease: a Mendelian randomization analysis. Stroke. 2018; 49:1325–31.
Article
60. Lucatelli P, Montisci R, Sanfilippo R, Sacconi B, Suri JS, Catalano C, et al. Is there an association between leukoaraiosis volume and diabetes? J Neuroradiol. 2016; 43:273–9.
Article
61. Luchsinger JA, Palta P, Rippon B, Sherwood G, Soto L, Ceballos F, et al. Pre-diabetes, but not type 2 diabetes, is related to brain amyloid in late middle-age. J Alzheimers Dis. 2020; 75:1241–52.
62. Maldjian JA, Whitlow CT, Saha BN, Kota G, Vandergriff C, Davenport EM, et al. Automated white matter total lesion volume segmentation in diabetes. AJNR Am J Neuroradiol. 2013; 34:2265–70.
Article
63. Manor B, Newton E, Abduljalil A, Novak V. The relationship between brain volume and walking outcomes in older adults with and without diabetic peripheral neuropathy. Diabetes Care. 2012; 35:1907–12.
Article
64. Moran C, Beare R, Phan TG, Bruce DG, Callisaya ML, Srikanth V, et al. Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology. 2015; 85:1123–30.
Article
65. Moran C, Tapp RJ, Hughes AD, Magnussen CG, Blizzard L, Phan TG, et al. The association of type 2 diabetes mellitus with cerebral gray matter volume is independent of retinal vascular architecture and retinopathy. J Diabetes Res. 2016; 2016:6328953.
Article
66. Musen G, Jacobson AM, Bolo NR, Simonson DC, Shenton ME, McCartney RL, et al. Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes. 2012; 61:2375–9.
Article
67. Novak V, Zhao P, Manor B, Sejdic E, Alsop D, Abduljalil A, et al. Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes. Diabetes Care. 2011; 34:2438–41.
Article
68. Peng B, Chen Z, Ma L, Dai Y. Cerebral alterations of type 2 diabetes mellitus on MRI: a pilot study. Neurosci Lett. 2015; 606:100–5.
Article
69. Qiu C, Sigurdsson S, Zhang Q, Jonsdottir MK, Kjartansson O, Eiriksdottir G, et al. Diabetes, markers of brain pathology and cognitive function: the Age, Gene/Environment Susceptibility-Reykjavik Study. Ann Neurol. 2014; 75:138–46.
70. Raffield LM, Cox AJ, Freedman BI, Hugenschmidt CE, Hsu FC, Wagner BC, et al. Analysis of the relationships between type 2 diabetes status, glycemic control, and neuroimaging measures in the Diabetes Heart Study Mind. Acta Diabetol. 2016; 53:439–47.
Article
71. Redel JM, DiFrancesco M, Vannest J, Altaye M, Beebe D, Khoury J, et al. Brain gray matter volume differences in obese youth with type 2 diabetes: a pilot study. J Pediatr Endocrinol Metab. 2018; 31:261–8.
Article
72. Reinhard H, Garde E, Skimminge A, Akeson P, Ramsoy TZ, Winther K, et al. Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients. Cardiovasc Diabetol. 2012; 11:119.
Article
73. Rensma SP, van Sloten TT, Ding J, Sigurdsson S, Stehouwer CD, Gudnason V, et al. Type 2 diabetes, change in depressive symptoms over time, and cerebral small vessel disease: longitudinal data of the AGES-Reykjavik Study. Diabetes Care. 2020; 43:1781–7.
Article
74. Roberts RO, Knopman DS, Przybelski SA, Mielke MM, Kantarci K, Preboske GM, et al. Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology. 2014; 82:1132–41.
Article
75. Roy B, Ehlert L, Mullur R, Freeby MJ, Woo MA, Kumar R, et al. Regional brain gray matter changes in patients with type 2 diabetes mellitus. Sci Rep. 2020; 10:9925.
Article
76. Saczynski JS, Siggurdsson S, Jonsson PV, Eiriksdottir G, Olafsdottir E, Kjartansson O, et al. Glycemic status and brain injury in older individuals: the age gene/environment susceptibility-Reykjavik study. Diabetes Care. 2009; 32:1608–13.
77. Shibata D, Suchy-Dicey A, Carty CL, Madhyastha T, Ali T, Best L, et al. Vascular risk factors and findings on brain MRI of elderly adult American Indians: the Strong Heart Study. Neuroepidemiology. 2019; 52:173–80.
Article
78. Sun Q, Chen GQ, Wang XB, Yu Y, Hu YC, Yan LF, et al. Alterations of white matter integrity and hippocampal functional connectivity in type 2 diabetes without mild cognitive impairment. Front Neuroanat. 2018; 12:21.
Article
79. Suzuki H, Venkataraman AV, Bai W, Guitton F, Guo Y, Dehghan A, et al. Associations of regional brain structural differences with aging, modifiable risk factors for dementia, and cognitive performance. JAMA Netw Open. 2019; 2:e1917257.
Article
80. Walsh EI, Shaw M, Sachdev P, Anstey KJ, Cherbuin N. The impact of type 2 diabetes and body mass index on cerebral structure is modulated by brain reserve. Eur J Neurol. 2019; 26:121–7.
Article
81. Wood AG, Chen J, Moran C, Phan T, Beare R, Cooper K, et al. Brain activation during memory encoding in type 2 diabetes mellitus: a discordant twin pair study. J Diabetes Res. 2016; 2016:3978428.
Article
82. Yau PL, Kluger A, Borod JC, Convit A. Neural substrates of verbal memory impairments in adults with type 2 diabetes mellitus. J Clin Exp Neuropsychol. 2014; 36:74–87.
Article
83. Zhang Y, Zhang X, Zhang J, Liu C, Yuan Q, Yin X, et al. Gray matter volume abnormalities in type 2 diabetes mellitus with and without mild cognitive impairment. Neurosci Lett. 2014; 562:1–6.
Article
84. Zhang YW, Zhang JQ, Liu C, Wei P, Zhang X, Yuan QY, et al. Memory dysfunction in type 2 diabetes mellitus correlates with reduced hippocampal CA1 and subiculum volumes. Chin Med J (Engl). 2015; 128:465–71.
Article
85. Peters R. Ageing and the brain. Postgrad Med J. 2006; 82:84–8.
Article
86. Tabatabaei-Jafari H, Shaw ME, Cherbuin N. Cerebral atrophy in mild cognitive impairment: a systematic review with meta-analysis. Alzheimers Dement (Amst). 2015; 1:487–504.
Article
87. Henneman WJ, Sluimer JD, Barnes J, van der Flier WM, Sluimer IC, Fox NC, et al. Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology. 2009; 72:999–1007.
Article
88. Cherbuin N, Sachdev P, Anstey KJ. Higher normal fasting plasma glucose is associated with hippocampal atrophy: the PATH Study. Neurology. 2012; 79:1019–26.
Article
89. Garfield V, Farmaki AE, Eastwood SV, Mathur R, Rentsch CT, Bhaskaran K, et al. HbA1c and brain health across the entire glycaemic spectrum. Diabetes Obes Metab. 2021; 23:1140–9.
Article
90. Li J, Shao YH, Gong YP, Lu YH, Liu Y, Li CL. Diabetes mellitus and dementia: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2014; 18:1778–89.
91. Vincent C, Hall PA. Executive function in adults with type 2 diabetes: a meta-analytic review. Psychosom Med. 2015; 77:631–42.
92. Zhou JB, Tang X, Han M, Yang J, Simo R. Impact of antidiabetic agents on dementia risk: a Bayesian network meta-analysis. Metabolism. 2020; 109:154265.
Article
93. Srikanth V, Sinclair AJ, Hill-Briggs F, Moran C, Biessels GJ. Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. Lancet Diabetes Endocrinol. 2020; 8:535–45.
Article
Full Text Links
  • DMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr